Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010 – 2012)

Author： Belluti Federica   Rampa Angela   Gobbi Silvia   Bisi Alessandra  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.5, 2013-05, pp. : 581-596

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of Amyloid-&bgr; Aggregation in Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 20, Iss. 8, 2014-03 ,pp. : 1223-1243

Bentham Science Publishers

Access to resources Recommend Favorite

Disrupting &bgr;-Amyloid Aggregation for Alzheimer Disease Treatment

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 1, 2007-01 ,pp. : 115-126

Bentham Science Publishers

Access to resources Recommend Favorite

Synthetic Curcumin Analogs as Inhibitors of β -Amyloid Peptide Aggregation: Potential Therapeutic and Diagnostic Agents for Alzheimer's Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 13, 2015-09 ,pp. : 1110-1121

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging amyloid beta (Ab) peptide modulators for the treatment of Alzheimer's disease (AD)

By Lukiw Walter J  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 2, 2008-06 ,pp. : 255-271

Informa Healthcare

Access to resources Recommend Favorite

A Direct Interaction Between Mitochondrial Proteins and Amyloid-β Peptide and its Significance for the Progression and Treatment of Alzheimer’s Disease

By  

Current Medicinal Chemistry, Vol. 22, Iss. 9, 2015-03 ,pp. : 1056-1085

Bentham Science Publishers

Access to resources Recommend Favorite